brolucizumab-dbll (Beovu) Report issue

Active Ingredient History

NOW
  • Now
Brolucizumab, is a humanized single-chain antibody fragment for the treatment of neovascular (wet) age-related macular degeneration (AMD).   Wikipedia

More Chemistry
  • Mechanisms of Action:
  • Multi-specific: No
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No
esba1008 | lmg324 | rth258

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue